About
Dr. Anuradha Dahiya earned her Doctor of Medicine degree from the University of Massachusetts Medical School in 1998. She holds board certification in internal medicine and brings advanced training in women's health to her practice. Her clinical specialties include preventive medicine, hormone replacement therapy, and weight management. She holds Biote Certified Provider status, offering bioidentical hormone replacement therapy through the Biote Method.
Dr. Dahiya chose medicine to make a meaningful difference in patients' lives. She takes a holistic approach, integrating evidence-based medicine with individualized treatment plans. Women's health holds particular importance for her; she sees it as the area where she creates the greatest clinical impact. She is passionate about hypertension management, GLP-1 therapies, and travel health. An active member of the American College of Physicians, she stays current with the latest advances in internal medicine. She serves patients in Rockville and across the region, with telehealth licenses covering Virginia and Washington, DC.
Education & Training
Medical School
University of Massachusetts Medical School, MD (1998)
Additional Training
Biote Certified Provider (Biote Method); Member, American College of Physicians
Certifications
Conditions Treated
Who is Dr. Dahiya right for?
Dr. Dahiya is a strong fit for adults seeking proactive, prevention-focused primary care. Women navigating hormonal changes, menopause, or reproductive health concerns benefit from her specialized focus. Patients managing chronic conditions like hypertension or diabetes find her medication management approach particularly effective. Adults interested in weight management or GLP-1 therapies also fit well in her practice. Her direct 24/7 access and same-day availability suit busy professionals across the Washington, DC metro area.
Similar Doctors Nearby
Dr. Matthew MintzMD, FACP
diabetes, asthma, COPD +4 more
Dr. Daphne KeshishianMD
chronic disease, diabetes, cardiovascular disease +5 more
Dr. Gerti TashkoMD
Diabetes, Thyroid Disorders, Obesity +11 more
Frequently Asked Questions
Dr. Dahiya specializes in preventive medicine, women's health, hormone replacement therapy, and weight management. She also treats hypertension, diabetes, and mental health concerns. Her clinical scope includes travel health, sexual health, and urgent care needs.
Yes, Dr. Dahiya holds board certification in internal medicine. She earned her MD from the University of Massachusetts Medical School in 1998 and has since built advanced expertise in preventive and functional medicine.
Yes, Dr. Dahiya offers hormone replacement therapy, including bioidentical hormone replacement therapy through the Biote Method. She holds Biote Certified Provider status and tailors hormone treatment plans to each patient's needs. She also provides testosterone therapy and menopause counseling.
Dr. Dahiya takes a holistic approach to weight management. She uses InBody body composition analysis to guide personalized strategies and offers GLP-1 prescription services. She also provides nutritional guidance and meal planning as part of each patient's plan.
Yes, Dr. Dahiya holds telehealth licenses in Maryland, Virginia, and Washington, DC. Patients outside Rockville can access her care through telehealth visits using any of those three jurisdictions.
Dr. Dahiya provides a full range of women's health services. These include annual Pap testing, birth control counseling and prescriptions, menopause counseling, and STD/STI testing. She also coordinates breast and cervical cancer screening referrals and treats vaginal infections and UTIs.
Yes, Dr. Dahiya is an active member of the American College of Physicians. This membership keeps her current with the latest clinical advances in internal medicine.
Yes, Dr. Dahiya serves both men and women at Elevate Concierge Medicine. Her men's health services include prostate examinations, hormone testing, and testosterone therapy, alongside full primary care and preventive services.
Doctor profile last updated March 21, 2026